![Rebecca Critchley-Thorne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rebecca Critchley-Thorne
Gründer bei Cernostics, Inc.
Aktive Positionen von Rebecca Critchley-Thorne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | - |
Gründer | 01.01.2008 | - | |
Corporate Officer/Principal | 16.06.2011 | 19.11.2014 |
Karriereverlauf von Rebecca Critchley-Thorne
Ehemalige bekannte Positionen von Rebecca Critchley-Thorne
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Acelerate, Inc.
![]() Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Rebecca Critchley-Thorne
Imperial College London | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
Acelerate, Inc.
![]() Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |